ON THE MENU
Stay tuned for upcoming event details.
BioTexas Cafe - Value in Innovation, Driving Patient Outcomes Through Scientific Advancements
Sponsored by Genentech, Novartis and Vertex
December 1, 2020
Join us for a policy discussion on the value of innovative genomic therapies, diagnostics and treatments, and alternative payment models. THBI's Policy Director Meredith Armstrong will lead this important conversation with guest speakers Tricia Fitzsimmons, Executive Director, Public Policy, Novartis, Scott McGoohan, JD, Senior Director, Government Affairs and Public Policy, Vertex Pharmaceuticals, and Casey O'Neill, Principal, Genentech.
PAST BIOTEXAS CAFE EVENTS
THBI President's Call with Special Guest, Mike Mattoon
This month's special guest Mike Mattoon, Vice President of Federal Government Relations at Biotechnology Innovation Organization (BIO) joins us for a federal update as we head into the election. Mike shared with members what he is seeing as we are now one week away from very important federal elections, and shared an outlook on how the different outcomes could effect the life sciences industry.
THBI President's Calls are member-only events. To learn how to access these events, email email@example.com.
BioTexas Cafe - The Promise of Personalized Medicine: CAR T-Cell Therapy
Sponsored by Bristol Myers Squibb
October 15, 2020
Special guest Dr. Michele Sharr McMahon, Director, Global Drug Development at Bristol Myers Squibb shares the work of her and her team on Novel cell-based therapies, such as CAR T, that use a person’s own cells are unlocking new potential in the fight against some of the most difficult-to-treat cancers. As a company on the forefront of scientific innovation, Bristol Myers Squibb is evaluating new and next-generation cell therapies and investing in technology to ensure that our health care system continues to support the development and access for these personalized treatments for patients today, and for the future.
THBI President's Call with Special Guest, Elliott Francis
Tom Kowalski, THBI's President and CEO, speaks with Elliott M. Francis, Director of Diversity and Inclusion at Biotechnology Innovation Organization (BIO). Elliott shares insight on his leadership role to drive change through the development and implementation of strategic diversity and inclusion initiatives in the biotechnology and life sciences industry, and within BIO.
BioTexas Cafe - A Discussion on COVID-19 Vaccines and Therapeutics
Co-Hosted by Texas Association of Manufacturers
In partnership with Texas Association of Manufacturers (TAM), Tom Kowalski, President and CEO of THBI, Tony Bennett, President and CEO of TAM, and our member companies provide an update on COVID-19 vaccines and therapeutics and how companies produce and distribute these products.
The Latest on COVID-19, A Town Hall Discussion
Sponsored by Amgen
THBI President's Call with Special Guest Wayne Roberts
THBI President's Call with Special Guests Tony Mitchell and Scott Newkirk
THBI President's Call with Special Guest Emma Schwartz
COVID-19 and the Important Role of Manufacturing
COVID-19 and the Importance of Policy on Public Health
This presentation was focused on the importance of public policy in fighting public health crises. Dr. Rodney Rohde, Professor and Chair for the Clinical Laboratory Science (CLS) Program in the College of Health Professions at Texas State University and Tom Kowalski, CEO of THBI discuss best practices policy leaders can learn from COVID-19 and how to be better prepared for the next virus.
THBI COVID-19 Webinar with Texas Biomedical Research Institute
Hear the latest COVID-19 research and development efforts being conducted at the Texas Biomedical Research Institute campus in San Antonio. Dr. Larry Schlesinger, CEO and Dr. Joanne Turner, Vice President for Research will discuss the Institute’s unique role in the bioscience landscape and how its team of researchers are tackling the newest threat – COVID-19 – followed by a Q&A!